Outlook Therapeutics Inc [OTLK] Is Currently -1.39 below its 200 Period Moving Avg: What Does This Mean?
Outlook Therapeutics Inc [NASDAQ: OTLK] loss -1.39% or -0.12 points to close at $8.51 with a heavy trading volume of 827569 shares. The company report on March 22, 2024 at 7:35 AM that Outlook Therapeutics® Receives European Union Positive CHMP Opinion for ONS-5010 as a